International Edition

Saturday

July, 30, 2016

Breaking News, World News and Taiwan News.
About Us
Subscribe
Advertise
Contact Us
 
 
More Health Topics
  Aging    AIDS    Allergies    Arthritis-Pains    
  Cancer    Children’s Health    Cold-Flu    
  Diabetes    Eye Health    Genetics    Heart    
  Hypertension    Infectious Diseases    
  Mental Health    
  Nutrition-Fitness    Oral Hygiene     
  Sexual Health     Skin-Beauty     
  Pregnancy-Menopause    Stroke    
  Surgical News    Other    
 
 
Health > Medicine
Some 3,000 more Cuban doctors are to arrive in Brazil from Monday to join a government program to fill vacancies in the country's public health system.
 
What do Siberian tigers and older women have in common?
 
Parents should limit kids' tweeting and texting and keep smartphones and laptops out of bedrooms, a pediatricians group says.
 
U.S. Food and Drug Administration advisers on Friday unanimously voted in favor of a highly anticipated hepatitis C drug from Gilead Sciences that holds promise for millions infected with the liver-destroying virus.
 
The European Medicines Agency (EMA) on Friday rejected a French request to tighten prescription guidelines on types of birth-control pills linked with a relatively higher risk of blood clots.
 
ScinoPharm Taiwan (台灣神隆) on Monday announced its new active pharmaceutical ingredient (API) for treating epilepsy has been ratified and launched by Supernus Pharmaceuticals in the U.S. market last week.
 
Taiwan's biotechnology sector yesterday saw a rapid decline, with the industry index losing 2.7 percent on the Taiwan Stock Exchange (TWSE), and down 3.3 percent on the over-the-counter-GreTai Securities Market. This was coupled with rocking reports concerning the beleaguered Legislative Yuan Speaker Wang Jin-pyng, who may be deposed before he can carry out policy amendments designed to benefit the sector.
 
Herbal medicine ingredient linked to cancer
Linkou Chang Gung Memorial Hospital yesterday published research showing that aristolochic acid is a carcinogen that can cause gene mutation.
 
The Department of Health recently approved a new targeted drug to treat patients suffering from late stage ALK-positive or metastatic non-small cell lung cancer (NSCLC).
 
Bringing a new medicine to market in Africa requires 54 separate applications to each country on the continent, a time-intensive process that could be costing lives. African leaders are now trying to move toward a regional and eventually continent-wide approach to speed the process.
 
Calendar  
  
1   2   3   4   5   6   7   8   9   10    <   Prev    Next   >
Subscribe  |   Advertise  |   RSS Feed  |   About Us  |   Career  |   Contact Us
Sitemap  |   Top Stories  |   Taiwan  |   China  |   Business  |   Asia  |   World  |   Sports  |   Life  |   Arts & Leisure  |   Health  |   Editorial  |   Commentary
Travel  |   Movies  |   TV Listings  |   Classifieds  |   Bookstore  |   Getting Around  |   Weather  |   Guide Post  |   Student Post  |   Terms of Use  |   Sitemap
  chinapost search